Gen Digital Inc. Stock News

Genesis HealthCare (“Genesis”) (GEN), one of the largest post-acute care providers in the United States, today announced that it received written notification from the New York Stock Exchange (the

A survey from the WSJ has found at least 10,700 COVID-related deaths at long-term care facilities among more than 35 states that either report data online or responded to requests for information.That

After Barclays and Robert W. Baird gave HCA Healthcare (NYSE: HCA) a Buy rating last month, the company received another Buy, this time from RBC Capital.

Michael Walker advanced the model where nursing homes were proactive centers of health care, rather than centers focused solely on custodial care for the elderly.

In a report released today, Frank Morgan from RBC Capital maintained a Hold rating on Brookdale (BKD), with a price target of $4.00. The company's shares

In a report released today, Frank Morgan from RBC Capital maintained a Hold rating on Brookdale (BKD – Research Report),

In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on Surgery Partners (SGRY), with a price target of $14.00. The company's

In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on Surgery Partners ( SGRY – Research Report ), with a price target of $14.00 . The company’s shares closed last M

RBC Capital analyst Frank Morgan maintained a Buy rating on Select Medical (SEM) today and set a price target of $26.00. The company's shares closed last

RBC Capital analyst Frank Morgan maintained a Buy rating on Select Medical ( SEM – Research Report ) today and set a price target of $26.00 . The company’s shares closed last Monday at $16.00. Acc

In a report released today, Frank Morgan from RBC Capital maintained a Hold rating on Pennant Group (PNTG), with a price target of $26.00. The company's

In a report released today, Frank Morgan from RBC Capital maintained a Hold rating on Pennant Group ( PNTG – Research Report ), with a price target of $26.00 . The company’s shares closed last Fri

In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on Acadia Healthcare (ACHC), with a price target of $34.00. The

In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on Acadia Healthcare (ACHC – Research

In a report released today, Frank Morgan from RBC Capital maintained a Hold rating on Fresenius Medical Care (FMS), with a price target of $42.00. The